Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder

Details for Australian Patent Application No. 2003239752 (hide)

International Classifications

Event Publications

11 September 2003 Complete Application Filed

Priority application(s): 60/392,140 27.06.02 US

4 March 2004 Application Open to Public Inspection

Published as AU-A-2003239752

10 February 2005 Amendment Made

The nature of the amendment is: Amend the invention title to read Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder

15 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.